Pharmaceutical News

NEWS ABOUT PHARMACEUTICALS IN MESOTHELIOMA TREATMENT

  1. Clinical Trials Starting Soon for Mesothelioma Drug
  2. Mesothelioma Drug Phase II Trials Starting Soon in Australia
  3. Targeting B-Cell Surface Proteins to Fight Cancer
  4. Mesothelioma and Cancer Research - Human Epidermal Growth Factor Receptor (HER) Signaling and Cancer Therapy
  5. Preparing for surgery - details to consider
  6. Mesothelioma and Cancer Research - the Hedgehog signaling pathway and cancer therapy
  7. Predicting the Effectiveness of Avastin
  8. New Mesothelioma Detection Test Ready for Distribution
  9. Mesothelioma Medication Alimta Receives Approval from UK Health Officials for Lung Cancer
  10. New Maintenance Therapy Methods for Lung Cancer
  11. Scientists at Karmanos Center Isolate Cause of Pleural Pain in Mesothelioma and Other Asbestos Diseases
  12. New Chemotherapy Combination to be tested on Mesothelioma Patients
  13. New Method Shows Promise in Improving Diagnostic Biomarker Cancer Tests
  14. Finnish Study Could Lead to Better Lung Cancer Drug
  15. New Lung Cancer Drug Starts Phase II Clinical Trial
  16. Gene Screening Proves Effective in Screening for Mesothelioma Survival
  17. Ohio University Finds Bond between Asbestos, Human Cell Tissue - Could Lead to Understanding of Mesothelioma Pathogenesis
  18. New Drug Regimen Aimed at Reducing Chemotherapy-Induced Nausea
  19. Ranpirnase and Doxorubicin Form Effective Second Line Treatment for Malignant Mesothelioma
  20. Gene Expression Ratio Test Can Predict Survival in Mesothelioma Cases
  21. Personalized Treatment Prolongs Survival For Advanced Cancer Patients
  22. BWH Researchers Identify Mutated Genes Unique to Mesothelioma Tumors - Brigham and Women's Hospital
  23. Cancer Diagnosis From a Single Drop of Blood?
  24. National mesothelioma virtual bank
  25. Another Study Links Nanotubes To Mesothelioma
  26. Retrofitted Antibodies Shrink Cancer Tumors and May Lead to HIV Vaccine
  27. FDA Tells Manufacturers to Stop Marketing Bogus Cancer Cures
  28. Morphotek Commences Phase II Study of MORAb-009 for Patients with MPM
  29. Research Shows Altered Immune Cells Target Mesothelin
  30. UK researchers predict rates of lung cancer will drop 20% over the next 20 years
  31. Breakthrough Could Lead to New Cancer Therapies
  32. Gene Fusions May Be Unique Identifier for Cancer
  33. Study Examines Interactions Between Asbestos Fibers and Cells
  34. Liver Tumors Treated with Chemotherapy Beads
  35. Mesothelioma Researcher Receives Two Grants
  36. The War on Mesothelioma: Researchers Announce Promising Results of Mesothelin-Based Immunotherapy
  37. Synthetic Material Attaches to Cells to Assist in Cancer Research
  38. Blood Vessel Growth Slowed with Common Chemotherapy Drugs, Slow Spread of Cancer
  39. FDA Recommends Additional Clinical Trial for Onconase
  40. ZenBio Awarded Phase II SBIR Grant for Cell Development
  41. Researchers gain new insight into DNA replication
  42. Study bolsters argument for treating cancer-related fatigue with exercise
  43. Study finds new chemotherapies to be ineffective in fighting asbestos-related cancer
  44. Researchers report promising gene that causes cancer cells to self destruct
  45. EPA awards $2.1 million asbestos research grant
  46. Cancer research may exclude older patients
  47. Vitamin supplements may not help prevent cancer
  48. New treatments under development for asbestos-related cancer
  49. Cancer treatment errors happen more than commonly known
  50. Scientists develop nanotube technology to fight cancer cells
  51. Study Shows Brief Inhibition of Cancer Cells is Effective
  52. Rosetta Genomics offers MicroRNA-based mesothelioma diagnostic test
  53. Vitamin trials for cancer prevention offer disappointing results
  54. Supressing tumors in young patients may increase cancer risk in later years
  55. Mistakes in Treatment Prompt Thorough Review in Southern Australia Hospitals
  56. Researchers Discover Enzyme That Signals Breast Cancer Metastasis
  57. Woman Campaigns for UK Chemoembolisation Trials After Successful Treatment
  58. Clinical trials struggling to attract participants
  59. Study finds chemotherapy may be harmful For patients with advanced cancer
  60. New cancer studies call anti-angiogenesis process into question
  61. Scientists explore ways to use genes to fight cancer
  62. Researchers find molecule that causes malignant cells to self-destruct
  63. Research sheds light on lung cancer for non-smokers
  64. Doctors look toward screening for lung cancer
  65. Nanomaterial Screening helps determine which particles are toxic
  66. Experts: Current pain treatment not sufficient for cancer patients
  67. Massage could be beneficial for reducing cancer pain
  68. New findings about chemotherapy at the molecular level
  69. Transdermal patch developed for severe cancer pain
  70. Too much Vitamin C may interfere with chemotherapy
  71. New clues on causes of thoracic cancer
  72. Telomerase gene sequence uncovered
  73. Pleurodesis in the treatment and care of mesothelioma patients
  74. Epigenetic drugs for cancer treatment
  75. Study shows Alimta effective for maintenance therapy
  76. Scientists announce advance in immunotherapy
  77. Minimally invasive RFA treatment could be used for several cancer types
  78. Novel strategy for cancer treatment uses patient's own blood
  79. Attacking cancer stem cells a way to treat cancer
  80. Predicting cancer-fighting abilities by computer
  81. Anti-inflammatory drugs investigated for chemoprevention
  82. Modified chemotherapy agent improves PET scan functioning
  83. Government budget cuts deter progress in fight against cancer
  84. Navelbine and cisplatin/pemetrexed in treatment of pleural mesothelioma
  85. Tumor Generator Could Enhance Cancer Drug Development
  86. Belgian doctors hit personalized cancer treatment milestone
  87. New biomarkers for cancer developed
  88. New cancer medicines track records fail to live up to hype
  89. New research initiative to map genetic mutations behind cancer
  90. Study suggests antioxidant supplements can have negative effects for cancer treatment patients.
  91. Personalized medicine holds promise
  92. Arenegyr Receives Orphan Drug Designation for Mesothelioma
  93. Onconase Phase IIIb Trial Posts Mixed Results
  94. Study finds inaccuracies in some cancer treatment research.
  95. Piroxicam and Cisplatin Show Promise Against Mesothelioma CellsCarbon nanotubes may be as deadly as asbestos
  96. New Study Tells Researchers How Cancer Spreads
  97. Researchers uncover reasons for patients' adverse reactions to Cetuximab.
  98. Study: Chemotherapy may not have any positive results on mesothelioma sufferers
  99. Synthetic Molecules May Help Battle Cancer
  100. Scientists Take a New Look at the Benefits of Fasting when Undergoing Chemotherapy
  101. Exercise Shown to Fend Off Fatigue Caused by Cancer
  102. Nanoparticles Could Deliver Cancer Drugs
  103. Meta-analysis of cancer clinical trials finds 41 percent are superior to existing treatments
  104. Vinflunine Shows Promise in Treating Malignant Pleural Mesothelioma
  105. Synthetic Molecules Could Offer A Lower Cost Cancer Treatment Alternative
  106. "Bacteria Therapy" Shows Promise in Initial Tests
  107. New UCLA Machine May Kill Cancer Cells
  108. Study raises doubts about some DNA-based drugs
  109. Disease-Causing Bugs May Help Treat Cancer
  110. New Cancer Vaccine Approved for Limited Use in Russia
  111. New Therapy Targets Hepatitis C
  112. Innovative New Cancer Treatment Idea Earns $1 Million Prize
  113. Higher Doses of Chemotherapy Make No Difference in Small Cell Lung Cancer
  114. Nanoparticles Help Advance Anticancer siRNA Therapy
  115. Research at MIT Shows microRNA's Protective Role
  116. Patients See Benefit From Self Reporting Symptoms Online
  117. Cancer drugs from genetically modified chicken eggs
  118. Researchers attempting to figure out how cancer grows
  119. Antifolates - Chemotherapy drugs
  120. Dopamine for cancer treatment
  121. Concerns about anemia medications for cancer patients
  122. Researchers Developing New Ways of Detecting Cancer
  123. Recentin Study Ends
  124. Phase II Study of Sutent ® Results Out
  125. Terminally Ill Cancer Patients Given Hope in UK
  126. New Finding on Correlation Between Angiogenesis, Breast Cancer and Inflammation
  127. PET Found to be effective in the Evaluation of Cancer Treatment
  128. One-tird of cancer patients experience chronic fatigue after treatment
  129. New Drug Cocktails Hold Promise for Cancer, HIV Treatments.
  130. New DNA Discovery Changes the Way Doctors Look at Cancer.
  131. Inraperitoneal Hyperthermic Chemotherapy for Those Suffering With Abdominal Cancer
  132. Mouse Model For Mesothelioma Reproduces Human Disease
  133. Researchers Use Transcriptome Analysis by 454 Sequencing to Identify Tumor Specific Mutations Linked to Malignant Pleural Mesothelioma
  134. Pre-Clinical Data Show Intracellular Pathways Affected by Onconase
  135. Remembering a researcher’s legacy on asbestos research
  136. PET proves effective in evaluating cancer treatment
  137. Trial on experimental antifolate PDX (Pralatrexate)
  138. American College of Physicians releases guidelines for end-of-life care
  139. Web-based system helps doctors track outpatients’ chemotherapy toxicity
  140. NICE Gives Final Approval for Alimta
  141. Par Pharmaceuticals licenses Onconase
  142. Thalidomide and Alimta to be Combined in New Clinical Trial
  143. Alfacell Updates Status Of ONCONASE(R) Phase III Clinical Program
  144. ONCONASE(R) has Potential as Chemopreventive Agent in Mesothelioma
  145. Boysenberries might impede mesothelioma
  146. Diagnostic Tools For Lung And Mesothelioma Cancers To Be Developed
  147. New Mesothelioma Research Center to Open in Sydney
  148. Virotherapy to Treat Mesothelioma
  149. MIT researchers' "nanocell" delivers a toxic double whammy to tumors
  150. FDA Approves the MESOMARK® Assay for the Management of Mesothelioma Patients
  151. NYU School of Medicine Verifies Mesothelioma Diagnostic Test
  152. Researchers Identify Intracellular Pathway of Alfacell's Onconase
  153. New Study Heralds Shortened Timeline for Anticancer Drug Development
  154. Talcum Powder Stunts Tumor Growth
  155. Soluble mesothelin in effusions a strong indicator of mesothelioma
  156. Diagnostic Tools For Lung And Mesothelioma Cancers To Be Developed
  157. New Technology For Cancer Screening Listens For The Signs Of Cancer
  158. Onconase(®) is in its final phase 3 trial for treatment of patients with unresectable malignant mesothelioma
  159. Data Affirm Benefit of ALIMTA(®) for Patients With Malignant Pleural Mesothelioma
  160. New diagnostic tool for mesothelioma to be developed: test will extract microRNAs from a simple blood draw
  161. The Barbara Ann Karmanos Cancer Institute announces significant scientific findings related to Malignant Mesothelioma
  162. Mild Hyperthermia Enhances Antitumor Effects of Ranpirnase
  163. Study shows Mesomark effective for monitoring Mesothelioma
  164. FDA Grants Orphan Drug status to Onconase for Mesothelioma
  165. Alfacell Corporation Files for U.S. Orphan Drug Designation for Onconase
  166. Additional Data From a Phase I Trial of XL647 in Patients With Advanced Solid Tumors
  167. New study on the safety, tolerability, pharmacokinetics and preliminary efficacy of INNO-305
  168. More evidence that patients treated with Onconase have greater median survival times than patients treated with doxorubicin alone
  169. Zolinza becomes first approved HDAC inhibitor
  170. Alimta Researchers Recognized As Heroes Of Chemistry
  171. Progress on Clinical Development Program for ONCONASE(R) in Malignant Mesothelioma
  172. FDA tells Eli Lilly that their Alimta brochure is misleading
  173. News about onocology product candidate SS1P (renamed CAT-5001)
  174. New Research Shows Unique Promise of Onconase in the Prevention and Treatment of Mesothelioma
  175. CuraGen and TopoTarget Announce Initiation of NCI-sponsored Phase II Clinical Trial with PXD101 for Mesothelioma
  176. Alfacell Provides Update on ONCONASE Phase IIIb Confirmatory Registration Trial; Releases First Interim Analysis Data
  177. Alfacell Achieves Full Patient Enrollment Milestone for the Onconase Phase IIIb Registration Study in Unresectable Malignant Mesothelioma
  178. Scientist Reveals His Hopes for Better Tumour Treatment
  179. Alfacell Drug Trial Ahead of Schedule
  180. Alfacell Forms New Thoracic Cancer Advisory Board
  181. Update on Onconase Clinical Program
  182. Promising Research in Early Detection of Mesothelioma
  183. Morphotek Announces IND Submission for MORAb-009, a Monoclonal Antibody for the Treatment of Mesothelin-Expressing Cancers
  184. INNOVIVE Pharmaceuticals Licenses WT1 Peptide Cancer Immunotherapeutic from Memorial Sloan-Kettering Cancer Center
  185. Gene Drug Gives Mesothelioma Patient Second Chance
  186. Novel therapies for pleural mesothelioma
  187. Thoracic Cancer Patients Find New Reasons for Hope with Alimta(®)
    188. MesotheliomaWeb News Stories
Subscribe to: Posts (Atom)